TY - CHAP M1 - Book, Section TI - Acute Coronary Syndromes A1 - Rogers, Kelly C. A1 - Spinler, Sarah A. A2 - Chisholm-Burns, Marie A. A2 - Schwinghammer, Terry L. A2 - Malone, Patrick M. A2 - Kolesar, Jill M. A2 - Bookstaver, P. Brandon A2 - Lee, Kelly C. PY - 2022 T2 - Pharmacotherapy Principles & Practice, 6e AB - LEARNING OBJECTIVESUpon completion of the chapter, the reader will be able to:Define the role of atherosclerotic plaque, platelets, and the coagulation system in an acute coronary syndrome (ACS).List key electrocardiographic (ECG), biomarker, and clinical features identifying a patient with non–ST-segment elevation (NSTE)-ACS and ST-segment elevation myocardial infarction (STEMI).Devise an initial, early pharmacotherapy treatment and monitoring plan for a patient presenting with either NSTE-ACS or STEMI given patient-specific data.Devise an antithrombotic pharmacotherapy treatment and monitoring plan for a patient with NSTE-ACS or STEMI undergoing percutaneous coronary intervention (PCI) given patient-specific data.Devise an antithrombotic pharmacotherapy treatment and monitoring plan for a patient with NSTE-ACS or STEMI not undergoing PCI given patient-specific data.Develop a pharmacotherapy and risk factor modification treatment plan for secondary prevention of coronary heart disease (CHD) events in a patient following NSTE-ACS or STEMI. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/10/07 UR - ppp.mhmedical.com/content.aspx?aid=1187007391 ER -